Publications | Lund University Publications

11 – 20 of 75

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=department+exact+v1001092&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
…
8
next »

2022
Mark Desmoglein-2 is important for islet function and β-cell survival
Myo Min, Kay K ; Rojas-Canales, Darling ; Penko, Daniella ; DeNichilo, Mark ; Cockshell, Michaelia P ; Ffrench, Charlie B ; Thompson, Emma J ; Asplund, Olof ^LU ; Drogemuller, Christopher J and Prasad, Rashmi B ^LU , et al. (2022) In Cell Death & Disease 13(10).
- Contribution to journal › Article
Mark Transcriptomic signatures of tumors undergoing T cell attack
Gokuldass, Aishwarya ; Schina, Aimilia ; Lauss, Martin ^LU ; Harbst, Katja ^LU ; Chamberlain, Christopher Aled ; Draghi, Arianna ; Westergaard, Marie Christine Wulff ; Nielsen, Morten ; Papp, Krisztian and Sztupinszki, Zsofia , et al. (2022) In Cancer Immunology, Immunotherapy 71(3). p.553-563
- Contribution to journal › Article
Mark Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
Sjödahl, Gottfrid ^LU ; Abrahamsson, Johan ^LU ; Holmsten, Karin ; Bernardo, Carina ^LU ; Chebil, Gunilla ; Eriksson, Pontus ^LU ; Johansson, Iva ^LU ; Kollberg, Petter ^LU ; Lindh, Claes and Lövgren, Kristina ^LU , et al. (2022) In European Urology 81(5). p.523-532
- Contribution to journal › Article
Mark DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
Sanna, Adriana ^LU ; Phung, Bengt ^LU ; Mitra, Shamik ^LU ; Lauss, Martin ^LU ; Choi, Jiyeon ; Zhang, Tongwu ; Njauw, Ching-Ni Jenny ; Cordero, Eugenia ^LU ; Harbst, Katja ^LU and Rosengren, Frida ^LU , et al. (2022) In JCI Insight 7(19).
- Contribution to journal › Article
Mark Neoantigen-reactive CD8⁺ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
Kristensen, Nikolaj Pagh ; Heeke, Christina ; Tvingsholm, Siri A. ; Borch, Annie ; Draghi, Arianna ; Crowther, Michael D. ; Carri, Ibel ; Munk, Kamilla K. ; Holm, Jeppe Sejerø and Bjerregaard, Anne Mette , et al. (2022) In Journal of Clinical Investigation 132(2).
- Contribution to journal › Article
2021
Mark Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kaminska, Kamila ^LU ; Akrap, Nina ^LU ; Staaf, Johan ^LU ; Alves, Carla L ; Ehinger, Anna ^LU ; Ebbesson, Anna ^LU ; Hedenfalk, Ingrid ^LU ; Beumers, Lukas ^LU ; Veerla, Srinivas ^LU and Harbst, Katja ^LU , et al. (2021) In Breast cancer research : BCR 23(1). p.26-26
- Contribution to journal › Article
Mark Tumour gene expression signature in primary melanoma predicts long-term outcomes
Garg, Manik ; Couturier, Dominique Laurent ; Nsengimana, Jérémie ; Fonseca, Nuno A. ; Wongchenko, Matthew ; Yan, Yibing ; Lauss, Martin ^LU ; Jönsson, Göran B. ^LU ; Newton-Bishop, Julia and Parkinson, Christine , et al. (2021) In Nature Communications 12(1).
- Contribution to journal › Article
Mark Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor
Nacer, Deborah F. ^LU ; Liljedahl, Helena ^LU ; Karlsson, Anna F ^LU ; Lindgren, David ^LU and Staaf, Johan ^LU (2021) In Briefings in Bioinformatics 22(6).
- Contribution to journal › Article
Mark Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
Borch, Troels Holz ; Harbst, Katja ^LU ; Rana, Aynal Haque ; Andersen, Rikke ; Martinenaite, Evelina ; Kongsted, Per ; Pedersen, Magnus ; Nielsen, Morten ; Kjeldsen, Julie Westerlin and Kverneland, Anders Handrup , et al. (2021) In Journal for ImmunoTherapy of Cancer 9(7).
- Contribution to journal › Article
Mark BRN2 is a non-canonical melanoma tumor-suppressor
Hamm, Michael ; Sohier, Pierre ; Petit, Valérie ; Raymond, Jérémy H. ; Delmas, Véronique ; Le Coz, Madeleine ; Gesbert, Franck ; Kenny, Colin ; Aktary, Zackie and Pouteaux, Marie , et al. (2021) In Nature Communications 12(1).
- Contribution to journal › Article

« previous
1
2
3
4
5
…
8
next »

your query:: Remove department: Melanoma Genomics